The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 14, 2023
Filed:
May. 17, 2019
Applicant:
Janssen Biotech, Inc., Horsham, PA (US);
Inventors:
Matteo Cesaroni, Philadelphia, PA (US);
Matthew Loza, Paoli, PA (US);
Jarrat Jordan, Norristown, PA (US);
Loqmane Seridi, Horsham, PA (US);
Assignee:
JANSSEN BIOTECH, INC., Horsham, PA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/24 (2006.01); A61K 9/00 (2006.01); A61P 37/06 (2006.01); G01N 29/44 (2006.01); G01N 33/483 (2006.01); G01N 33/564 (2006.01); C12Q 1/6883 (2018.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/244 (2013.01); A61K 9/0019 (2013.01); A61P 37/06 (2018.01); C07K 16/249 (2013.01); C12Q 1/6883 (2013.01); G01N 29/4418 (2013.01); G01N 33/483 (2013.01); G01N 33/564 (2013.01); A61K 2039/505 (2013.01); A61K 2039/545 (2013.01); C07K 2317/21 (2013.01); C07K 2317/76 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/158 (2013.01); G01N 2333/555 (2013.01);
Abstract
Methods for selecting and treating patients with active Systemic Lupus Erythematosus (SLE) that are predicted to have an increased likelihood of having a positive response to a treatment with a safe and effective amount of an anti-IL-12/IL-23p40 antibody or an anti-IL-23 antibody, e.g., informs on what patients to treat with the anti-IL-12/IL-23p40 antibody ustekinumab.